In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Merck unit Biovation agrees development pact with Roche
BIOVATION SIGNS RESEARCH AGREEMENT WITH PFIZER
Procyon receives Canadian tumour patent
Procyon gains additional patent protection for cancer screening test
Procyon enters into cancer technology option agreement
Viventia and Biovation form collaboration
Procyon enters into a license option agreement